These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8018409)

  • 1. Identification of p53 mutations by means of single strand conformation polymorphism analysis in gynaecological tumours: comparison with the results of immunohistochemistry.
    Schneider J; Rubio MP; Rodriguez-Escudero FJ; Seizinger BR; Castresana JS
    Eur J Cancer; 1994; 30A(4):504-8. PubMed ID: 8018409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors.
    Schneider J; Rubio MP; Barbazán MJ; Rodriguez-Escudero FJ; Seizinger BR; Castresana JS
    J Natl Cancer Inst; 1994 Jun; 86(11):850-5. PubMed ID: 7910219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between p53 mutations and antibody staining in breast carcinoma.
    Dunn JM; Hastrich DJ; Newcomb P; Webb JC; Maitland NJ; Farndon JR
    Br J Surg; 1993 Nov; 80(11):1410-2. PubMed ID: 8252351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutations and histological type of invasive breast carcinoma.
    Marchetti A; Buttitta F; Pellegrini S; Campani D; Diella F; Cecchetti D; Callahan R; Bistocchi M
    Cancer Res; 1993 Oct; 53(19):4665-9. PubMed ID: 8402644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low frequency of p53 mutations in human thyroid tumours; p53 and Ras mutation in two out of fifty-six thyroid tumours.
    Salvatore D; Celetti A; Fabien N; Paulin C; Martelli ML; Battaglia C; Califano D; Monaco C; Viglietto G; Santoro M; Fusco A
    Eur J Endocrinol; 1996 Feb; 134(2):177-83. PubMed ID: 8630516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53 in breast carcinomas: association between presence of mutation and immunohistochemical expression using a semiquantitative approach.
    Schmitt FC; Soares R; Cirnes L; Seruca R
    Pathol Res Pract; 1998; 194(12):815-9. PubMed ID: 9894246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutations and overexpression in locally advanced breast cancers.
    Faille A; De Cremoux P; Extra JM; Linares G; Espie M; Bourstyn E; De Rocquancourt A; Giacchetti S; Marty M; Calvo F
    Br J Cancer; 1994 Jun; 69(6):1145-50. PubMed ID: 8198984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 Gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: correlation between immunohistochemical and molecular biology techniques.
    Hurlimann J; Chaubert P; Benhattar J
    Mod Pathol; 1994 May; 7(4):423-8. PubMed ID: 8066070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of detection of p53 mutations in human breast cancer by flow cytometry, single-strand conformation polymorphism and genomic sequencing.
    Chakravarty G; Redkar A; Mittra I
    Br J Cancer; 1996 Oct; 74(8):1181-7. PubMed ID: 8883402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
    Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW
    J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas.
    Dix B; Robbins P; Carrello S; House A; Iacopetta B
    Br J Cancer; 1994 Oct; 70(4):585-90. PubMed ID: 7917901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck.
    Nylander K; Nilsson P; Mehle C; Roos G
    Br J Cancer; 1995 Apr; 71(4):826-30. PubMed ID: 7710950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.
    Chang F; Syrjänen S; Tervahauta A; Kurvinen K; Wang L; Syrjänen K
    Br J Cancer; 1994 Aug; 70(2):346-51. PubMed ID: 8054284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes.
    Tsuda H; Hirohashi S
    Jpn J Cancer Res; 1992 Nov; 83(11):1184-91. PubMed ID: 1336492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus.
    Jeffers MD; Farquharson MA; Richmond JA; McNicol AM
    J Pathol; 1995 Sep; 177(1):65-70. PubMed ID: 7472782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
    Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
    Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas.
    Patterson H; Gill S; Fisher C; Law MG; Jayatilake H; Fletcher CD; Thomas M; Grimer R; Gusterson BA; Cooper CS
    Br J Cancer; 1994 Jun; 69(6):1052-8. PubMed ID: 8198970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer.
    Dahiya R; Deng G; Chen KM; Chui RM; Haughney PC; Narayan P
    Br J Cancer; 1996 Jul; 74(2):264-8. PubMed ID: 8688333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
    Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
    Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting p53 gene mutation of breast cancer and defining differences between silver staining PCR-SSCP and immunohistochemical staining.
    Ryu JW; Lee MC; Jang WC
    J Korean Med Sci; 2000 Feb; 15(1):73-7. PubMed ID: 10719813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.